Royal Free London NHS foundation Trust
London, NW3 2QG, United Kingdom
NCT Number: NCT04179123
This study is a single site pilot and feasibility study. We propose that 3D printing could be used to create customised masks for patients requiring Positive Airway Pressure (PAP) therapy. We hypothesise that the use of this technology may result in; improved compliance with therapy, increased comfort, reduced side effects, increased quality of life and reduced healthcare costs.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
London, NW3 2QG, United Kingdom
Stage 1:
10 health participants. subjects will be asked to attend for a mask fitting using off the shelf standard mask stock. They will then be trialed on PAP therapy (breathing machine) for 10 minutes. Mask leak, skin reactions and comfort scores will be assessed.
Subjects will then attend for 3D printing of a mask. Following the production of the 3D mask, repeat measurements with the 3d mask on PAP therapy will be taken.
If all healthy subjects complete the trial without any serious adverse events, then the second phase of the study with patients will commence.
Stage 2:
Patients with an established diagnosis of sleep disordered breathing with known mask concerns will be recruited from the Royal Free London NHS Foundation Trust (RFL) Sleep and Ventilation Service. Subjects will be asked to attend for a mask fitting using their existing mask standard stock and will be trialed on PAP therapy (breathing machine) for 10 minutes. Mask leak, skin reactions and comfort scores will be assessed. Any side effects will be documented via photographs. The number and cost of previous masks used since starting PAP therapy (breathing machine) will be also be recorded.
Patients will then attend for 3D printing of a mask and repeat measurements with the 3D mask on 10 minutes of their usual PAP therapy will be taken. If there are no serious adverse events/reactions during the PAP trial with the 3D printed mask patients will go on to have a one-night trial on PAP therapy as per their normal PAP (breathing machine) regime. If there are no adverse events or reactions during the one-night trial then patients will proceed to a further four nights of trial with the 3D printed mask. A comparison of scores will be made with standard and 3D printed masks.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Healthy:
Inclusion criteria
Exclusion criteria
Patients
Inclusion criteria
Exclusion criteria
Customised PAP interfaces
Time frame: 5 days
Acceptability of 3D printed customised PAP masks by patients and healthcare professionals
Time frame: 5 days
Measured with self developed mask comfort questionnaire. Combination of questions answered on a Visual Analogue Scale (1-5) scale, open questions and binary questions. No overall score produced
Time frame: 5 days
Measured with self developed mask comfort questionnaire. Combination of questions answered on a VAS scale, open questions and binary questions. No overall score produced.
Objective assessment of skin to assess for skin reactions, graded with the EUPAP 0-4.
Time frame: 5 days
Measured via SD data card download. Leak a l/min as an average over 5 nights
University College, London
Other
Acronym: 3DPiPPIn
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04254484
Apnea, Brain Diseases
Chicago, Illinois, United States
View Trial DetailsNCT02191085
Apnea, Dyssomnias
Calgary, Alberta, Canada
View Trial DetailsNCT03964376
Apnea, Dyssomnias
Toronto, Ontario, Canada
View Trial DetailsNCT03718858
Apnea, Dyssomnias
Toronto, ON Ontario, Canada
View Trial Details